Preparation of potent macrophage activating factors derived from cloned vitamin d binding protein and its domain and their therapeutic usage for cancer, hiv-infection and osteopetrosis
USPTO Application #: 20060014143
Title: Preparation of potent macrophage activating factors derived from cloned vitamin d binding protein and its domain and their therapeutic usage for cancer, hiv-infection and osteopetrosis
Abstract: Vitamin D-binding protein (Gc protein) and its small domain (approximately ⅕ of the Gc peptide also known as domain III) were cloned via a baculovirus vector. The cloned Gc protein and the cloned domain (Cd) peptide were treated with immobilized β-galactosidase and sialidase to yield macrophage activating factors, GcMAFc and CdMAF, respectively. These cloned macrophage activating factors and GcMAF are to be used for therapy of cancer, HIV-infection and osteopetrosis, and may also be used as adjuvants for
[COLOR=blue ! important][COLOR=blue ! important]immunization[/COLOR][/COLOR] and vaccination.
(end of abstract)
Agent: Caesar, Rivise, Bernstein, Cohen & Pokotilow, Ltd. -
Philadelphia, PA, US
Inventor: Nobuto Yamamoto
USPTO Applicaton #: 20060014143 -
Class: 435005000 (USPTO)
Full Patent Description